Treatment of Bladder Cancer: From Past to Future
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 508
Special Issue Editor
Special Issue Information
Dear Colleagues,
Bladder cancer is a frequent cancer type with a high degree of diversity regarding its prognosis and treatment modalities. The incidence of bladder cancer has been almost unaltered over the past decades despite the focus on smoking and work enviromental improvements. Thus, the reduction in these factors has been upweighted by an increasing life expectancy in the Western World. During the last decade, previous stagnation in the development of new treatment modalities has changed into an explosion of new local and systemic treatments. Immuotherapy showed promising results when introduced, but the initial enthusiasm was quickly changed to a more realistic expectation of a game changer in just a minority of patients; however, this fact has paved the way for more individualized tailor-made treametments. We are on the verge of a new future for bladder cancer treatments. With this Special Issue, we hope to focus on an up-to-date mapping of the current status of bladder cancer and highlight new promising fields of diagnostics, treatments, and follow-ups.
Prof. Dr. Jørgen Bjerggaard Jensen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urology
- bladder cancer
- urothelial cancer
- nonmuscle-invasive bladder cancer
- muscle-invasive bladder cancer
